worsened the TB scenario. Treatment of MDR TB requires the use of more costly and more toxic second-line drugs and is associated with higher mortality rates than drug-sensitive TB, particularly in immunocompromised patients. A delay in the diagnosis of MDR TB associated with standard drug susceptibility testing (DST) methods is likely to contribute to the transmission of resistant isolates. Therefore, there is a great need for use of rapid methods for identification and drug susceptibility testing of M. tuberculosis isolates and hence the need to evaluate these methods for their sensitivity and accuracy in Indian settings prior to implementation. Rapid detection and monitoring of anti-TB drug resistance pattern in TB patients in general and HIV Seropositive tuberculosis patients in particular, would provide important data, which may be crucial for the National Tuberculosis Control Programme.
Multidrug resistant tuberculosis (MDR-TB) poses a formidable challenge to TB control due to its complex diagnostic and treatment challenges.
Conventional methods for mycobacteriological culture and drug susceptibility testing (DST) are slow and cumbersome, requiring sequential procedures for isolation of mycobacteria from clinical specimens, identification and testing of susceptibility to anti-TB drugs.
The objective of this work is to evaluate the sensitivity and accuracy of rapid anti-TB drug resistance detection methods; Microscopic
Observation of Drug Susceptibility (MODS) and BACTEC MGIT 960 and detection of mutations associated with anti-TB drug resistance in Mycobacterium tuberculosis in Pune, India.
Current Status
A total of 280 sputum samples have been processed under this study and the study is ongoing. 
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